RNAZ - Transcode Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Transcode Therapeutics's activity chart (see below) currently has 4 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from HC WAINWRIGHT on 16-Apr-2025. First documented stock forecast 07-Jun-2022.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jun-2022

$7840

$7835.03 (157646.48%)

1 years 5 months 4 days ago
(16-Apr-2025)

0/4 (0%)

$7830.02 (78457.11%)

Show more analysts

Which analyst most recently updated their price target on RNAZ (Transcode Therapeutics)?

Which analyst has the most public recommendations on RNAZ (Transcode Therapeutics)?

has 0 price targets and 0 ratings on RNAZ

Which analyst is the currently most bullish on RNAZ (Transcode Therapeutics)?

Emily Bodnar with the highest potential upside of $7838.35

Which analyst is the currently most reserved on RNAZ (Transcode Therapeutics)?

Emily Bodnar with the lowest potential downside of $7835.03